Notification
No new Notification messages
Zinka Logistics Solutions IPO is Open!
Apply for the Zinka Logistics Solutions IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
metropolis healthcare ltd stock

METROPOLIS HEALTHCARE LTD Share Price

2015.15 -5.54 (-0.27%)
Nov 21 2024 03:29 PM Healthcare NSE: METROPOLIS

METROPOLIS HEALTHCARE LTD Share Price Update

As of the latest trading session, METROPOLIS HEALTHCARE LTD share price is currently at 2015.15, which is down by -5.54 from its previous closing. Today, the stock has fluctuated between 1988.15 and 2021.45. Over the past year, METROPOLIS HEALTHCARE LTD has achieved a return of 23.12 %. In the last month alone, the return has been -7.15 %. Read More...

METROPOLIS HEALTHCARE LTD Performance

Day Range

Low1988.15 High2021.45
2015.75

52 Week Range

Low 1450.00 High 2318.30
2015.75

METROPOLIS HEALTHCARE LTD Share Price

9581

542650

METROPOLIS

img img img img
No Data Available

Open Price

2007.80

Prev. Close

2020.70

Volume (Shares)

75288.00

Total traded value

1517.61

Upper Circuit

2222.75

Lower Circuit

1818.65

Note: The current prices & values are delayed, Login to your account for live updates.

METROPOLIS HEALTHCARE LTD Fundamentals


(Standalone)

Market Cap (Cr) 10322.98
PE Ratio (TTM) 78.30
Book Value / Share 215.69
Beta 0.73
ROE 11.78%
EPS (TTM) 25.75
Dividend Yield 0.20%
Net Profit Qtr (Cr) 42.26

METROPOLIS HEALTHCARE LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 321.57
Operating Expense 270.29
Net Profit 42.26
Net Profit Margin (%) 13.14
Earnings Per Share (EPS) 8.24
EBITDA 85.61
Effective Tax Rate (%) 22.96
Particulars JUN 2024 (Values in Cr)
Revenue 286.14
Operating Expense 247.24
Net Profit 31.28
Net Profit Margin (%) 10.93
Earnings Per Share (EPS) 6.11
EBITDA 71.09
Effective Tax Rate (%) 25.02
Particulars MAR 2024 (Values in Cr)
Revenue 292.27
Operating Expense 249.23
Net Profit 31.78
Net Profit Margin (%) 10.87
Earnings Per Share (EPS) 6.20
EBITDA 75.94
Effective Tax Rate (%) 29.45
Particulars DEC 2023 (Values in Cr)
Revenue 269.41
Operating Expense 239.96
Net Profit 26.70
Net Profit Margin (%) 9.91
Earnings Per Share (EPS) 5.21
EBITDA 64.01
Effective Tax Rate (%) 22.89
Particulars SEP 2023 (Values in Cr)
Revenue 285.46
Operating Expense 244.97
Net Profit 31.28
Net Profit Margin (%) 10.95
Earnings Per Share (EPS) 6.11
EBITDA 69.48
Effective Tax Rate (%) 26.38
Particulars MAR 2024 (Values in Cr)
Revenue 1103.43
Operating Expense 958.02
Net Profit 115.89
Net Profit Margin (%) 10.50
Earnings Per Share (EPS) 22.63
EBITDA 270.48
Effective Tax Rate (%) 26.37
Particulars MAR 2023 (Values in Cr)
Revenue 1066.04
Operating Expense 908.38
Net Profit 138.95
Net Profit Margin (%) 13.03
Earnings Per Share (EPS) 27.14
EBITDA 290.59
Effective Tax Rate (%) 22.35
Particulars MAR 2022 (Values in Cr)
Revenue 1157.01
Operating Expense 917.51
Net Profit 199.53
Net Profit Margin (%) 17.24
Earnings Per Share (EPS) 39.00
EBITDA 351.41
Effective Tax Rate (%) 26.51
Particulars MAR 2021 (Values in Cr)
Revenue 961.39
Operating Expense 731.56
Net Profit 182.65
Net Profit Margin (%) 18.99
Earnings Per Share (EPS) 35.88
EBITDA 293.58
Effective Tax Rate (%) 24.56
Particulars MAR 2020 (Values in Cr)
Revenue 665.31
Operating Expense 530.10
Net Profit 112.05
Net Profit Margin (%) 16.84
Earnings Per Share (EPS) 22.32
EBITDA 177.40
Effective Tax Rate (%) 19.95
Particulars MAR 2024 (Values in Cr)
Book Value / Share 213.98
ROE % 12.33
ROCE % 15.72
Total Debt to Total Equity 0.22
EBITDA Margin 24.60
Particulars MAR 2023 (Values in Cr)
Book Value / Share 192.97
ROE % 15.30
ROCE % 17.23
Total Debt to Total Equity 0.34
EBITDA Margin 26.87
Particulars MAR 2022 (Values in Cr)
Book Value / Share 173.18
ROE % 26.96
ROCE % 30.24
Total Debt to Total Equity 0.31
EBITDA Margin 31.07
Particulars MAR 2021 (Values in Cr)
Book Value / Share 138.23
ROE % 29.81
ROCE % 35.83
Total Debt to Total Equity 0.15
EBITDA Margin 30.24
Particulars MAR 2020 (Values in Cr)
Book Value / Share 103.40
ROE % 30.60
ROCE % 39.47
Total Debt to Total Equity 0.09
EBITDA Margin 28.59
Particulars MAR 2024 (Values in Cr)
Book Value / Share 201.30
ROE % 11.78
ROCE % 15.02
Total Debt to Total Equity 0.24
EBITDA Margin 24.96
Particulars MAR 2023 (Values in Cr)
Book Value / Share 182.78
ROE % 15.65
ROCE % 17.19
Total Debt to Total Equity 0.36
EBITDA Margin 27.69
Particulars MAR 2022 (Values in Cr)
Book Value / Share 164.00
ROE % 26.53
ROCE % 29.41
Total Debt to Total Equity 0.32
EBITDA Margin 30.80
Particulars MAR 2021 (Values in Cr)
Book Value / Share 130.06
ROE % 31.03
ROCE % 37.36
Total Debt to Total Equity 0.14
EBITDA Margin 30.91
Particulars MAR 2020 (Values in Cr)
Book Value / Share 101.20
ROE % 27.96
ROCE % 34.60
Total Debt to Total Equity 0.08
EBITDA Margin 30.87
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 71.21
Total Assets 1555.06
Total Liabilities 1555.06
Total Equity 1099.27
Share Outstanding 51226861
Price to Book Ratio 8.58
Return on Assets (%) 8.21
Return on Capital (%) 11.63
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 93.19
Total Assets 1501.60
Total Liabilities 1501.60
Total Equity 990.71
Share Outstanding 51210664
Price to Book Ratio 6.83
Return on Assets (%) 9.51
Return on Capital (%) 13.36
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 166.93
Total Assets 1530.29
Total Liabilities 1530.29
Total Equity 888.16
Share Outstanding 51172119
Price to Book Ratio 12.42
Return on Assets (%) 13.99
Return on Capital (%) 18.68
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 419.69
Total Assets 1004.41
Total Liabilities 1004.41
Total Equity 708.06
Share Outstanding 51116813
Price to Book Ratio 17.23
Return on Assets (%) 18.22
Return on Capital (%) 25.86
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 210.47
Total Assets 752.23
Total Liabilities 752.23
Total Equity 525.15
Share Outstanding 50630566
Price to Book Ratio 12.71
Return on Assets (%) 16.92
Return on Capital (%) 24.25
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 30.46
Total Assets 1472.70
Total Liabilities 1472.70
Total Equity 1031.18
Share Outstanding 51226861
Price to Book Ratio 8.58
Return on Assets (%) 7.86
Return on Capital (%) 11.24
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 42.94
Total Assets 1434.29
Total Liabilities 1434.29
Total Equity 936.01
Share Outstanding 51210664
Price to Book Ratio 6.83
Return on Assets (%) 9.68
Return on Capital (%) 13.64
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 115.35
Total Assets 1458.54
Total Liabilities 1458.54
Total Equity 839.20
Share Outstanding 51172119
Price to Book Ratio 12.42
Return on Assets (%) 13.68
Return on Capital (%) 18.18
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 380.62
Total Assets 939.12
Total Liabilities 939.12
Total Equity 664.80
Share Outstanding 51116813
Price to Book Ratio 17.23
Return on Assets (%) 19.44
Return on Capital (%) 27.47
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 132.00
Total Assets 688.29
Total Liabilities 688.29
Total Equity 512.38
Share Outstanding 50630566
Price to Book Ratio 12.71
Return on Assets (%) 16.27
Return on Capital (%) 21.87
Particulars MAR 2024 (Values in Cr)
Net Income 174.68
Cash from Operations 301.45
Cash from Investing -89.41
Cash from Financing -181.19
Net change in Cash -6.54
Free Cash Flow 365.21
Particulars MAR 2023 (Values in Cr)
Net Income 187.50
Cash from Operations 298.66
Cash from Investing 46.79
Cash from Financing -292.32
Net change in Cash 1.55
Free Cash Flow 351.30
Particulars MAR 2022 (Values in Cr)
Net Income 293.35
Cash from Operations 335.78
Cash from Investing -737.57
Cash from Financing 162.52
Net change in Cash -321.77
Free Cash Flow 366.44
Particulars MAR 2021 (Values in Cr)
Net Income 244.32
Cash from Operations 305.86
Cash from Investing 61.70
Cash from Financing -32.69
Net change in Cash 278.03
Free Cash Flow 334.13
Particulars MAR 2020 (Values in Cr)
Net Income 168.73
Cash from Operations 279.42
Cash from Investing -104.83
Cash from Financing -55.32
Net change in Cash 54.84
Free Cash Flow 315.63
Particulars MAR 2024 (Values in Cr)
Net Income 157.40
Cash from Operations 296.26
Cash from Investing -81.00
Cash from Financing -182.99
Net change in Cash 5.00
Free Cash Flow 329.01
Particulars MAR 2023 (Values in Cr)
Net Income 178.94
Cash from Operations 281.76
Cash from Investing 46.72
Cash from Financing -287.86
Net change in Cash -3.40
Free Cash Flow 288.80
Particulars MAR 2022 (Values in Cr)
Net Income 271.54
Cash from Operations 320.21
Cash from Investing -738.21
Cash from Financing 171.97
Net change in Cash -322.19
Free Cash Flow 357.15
Particulars MAR 2021 (Values in Cr)
Net Income 242.12
Cash from Operations 291.29
Cash from Investing 59.41
Cash from Financing -31.26
Net change in Cash 264.37
Free Cash Flow 317.83
Particulars MAR 2020 (Values in Cr)
Net Income 139.99
Cash from Operations 203.74
Cash from Investing -51.12
Cash from Financing -46.37
Net change in Cash 58.63
Free Cash Flow 226.48
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6681.60 81.21 12.82 96071.16 5286.00 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 53.50 0.00 3.36 100.27 44.00 / 107.94
SHREE PACETRONIX LTD. 121.20 19.52 3.24 43.62 114.95 / 316.85
TRANSGENE BIOTEK LTD. 6.73 0.00 4.70 50.99 5.79 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6681.60 85.55 11.72 96071.16 5286.00 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 38.70 0.00 -20.73 28.91 28.42 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 5335.90 28.94 5.99 5837.47 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 2053.80
  • 26 Days 2135.40
  • 10 Days 2077.00
  • 50 Days 2145.50
  • 12 Days 2089.20
  • 100 Days 2109.40
  • 20 Days 2109.30
  • 200 Days 1654.60
2030.50
PIVOT
First Resistance 2049.85
Second Resistance 2079.00
Third Resistance 2098.35
First Support 2001.35
Second Support 1982.00
Third Support 1952.85
RSI 39.13
MACD -46.21
Commodity Channel Index (CCI) -192.21
ADX 48.20
Williams % R -89.91

Over 1 Month

down

-7.15

Over 3 Months

down

-4.68

Over 6 Months

down

6.19

Over 1 Year

down

23.12

Over 3 Years

down

-12.62

Over 5 Years

down

7.50

METROPOLIS HEALTHCARE LTD Future

Future: Price

28 Nov
2021.80
26 Dec
2031.00
25 May
0 100 200 300 400 500 600

Discount/Premium

28 Nov
6.65
26 Dec
15.85
25 May
0 1 2 3 4 5 6 7

Active Calls

2200.0
527
2100.0
266
2300.0
175
25 May
0 500 1000 1500 2000 2500 3000

Active Puts

2000.0
309
1980.0
42
1900.0
41
25 Jul
0 500 1000 1500 2000 2500

METROPOLIS HEALTHCARE LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
7.68
Promoter Holdings
49.42
FII
18.56
DII
24.32
Promoter Shares(Pledge Percentage)
1.18
Name Category Shares Shares%
Metz Advisory Llp Shareholding of Promoter and Promoter Group 1.5691216E7 30.62
Duru Shah Family Trust Shareholding of Promoter and Promoter Group 4964026.0 9.69
Hdfc Mutual Fund - Hdfc Focused 30 Fund Public Shareholding 4835187.0 9.44
Uti Large Cap Fund Public Shareholding 2569895.0 5.02
Sushil Shah Family Trust Shareholding of Promoter and Promoter Group 2558187.0 4.99
Franklin India Smaller Companies Fund Public Shareholding 1557703.0 3.04
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund Public Shareholding 1173345.0 2.29
Sushil Kanubhai Shah Shareholding of Promoter and Promoter Group 1167058.0 2.28
Sbi Life Insurance Co. Ltd Public Shareholding 1131676.0 2.21
J P Morgan Funds Public Shareholding 975006.0 1.9
Duru Sushil Shah Shareholding of Promoter and Promoter Group 765659.0 1.49
Caisse De Depot Et Placement Du Quebec - First Sentier Investors International Im Limited Public Shareholding 714412.0 1.39
Fssa Indian Subcontinent Fund As Sub Fund Of First Sentier Investors Global Umbrella Fund Plc Public Shareholding 626081.0 1.22
Jpmorgan Indian Investment Trust Plc Public Shareholding 619821.0 1.21
Canara Robeco Mutual Fund A/c Canara Robeco Small Cap Fund Public Shareholding 621930.0 1.21
Aditya Birla Sun Life Trustee Private Limited A/c Aditya Birla Sun Life Flexi Cap Fund Public Shareholding 598072.0 1.17
The Scottish Oriental Smaller Companies Trustplc Public Shareholding 588608.0 1.15
Ameera Sushil Shah Shareholding of Promoter and Promoter Group 181845.0 0.35

METROPOLIS HEALTHCARE LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-11-17 4.0 Interim 2023-11-17 Equity shares 2023-02-23 8.0 Interim 2023-02-23 Equity shares 2022-02-21 8.0 Interim 2022-02-22 Equity shares 2021-02-17 8.0 Interim 2021-02-19 Equity shares 2020-02-13 8.0 Interim 2020-02-15 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About METROPOLIS HEALTHCARE LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by METROPOLIS HEALTHCARE LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Metropolis Healthcare Ltd?

Answer Field

The share price of Metropolis Healthcare Ltd for NSE is ₹ 2015.15 and for BSE is ₹ 2012.05.

What is the Market Cap of Metropolis Healthcare Ltd?

Answer Field

The market cap of Metropolis Healthcare Ltd for NSE is ₹ 1,03,22.98 Cr. and for BSE is ₹ 1,03,07.10 Cr. as of now.

What is the 52 Week High and Low of Metropolis Healthcare Ltd?

Answer Field

The 52 Week High and Low of Metropolis Healthcare Ltd for NSE is ₹ 2318.30 and ₹ 1450.00 and for BSE is ₹ 2306.85 and ₹ 1450.05.

How to Buy Metropolis Healthcare Ltd share?

Answer Field

You can trade in Metropolis Healthcare Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Metropolis Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been 23.12%.

What is the Current Share Price of Metropolis Healthcare Ltd?

Answer Field

Metropolis Healthcare Ltd share price is for NSE ₹ 2015.15 & for BSE ₹ 2012.05 as on Nov 21 2024 03:29 PM.

What is the Market Cap of Metropolis Healthcare Ltd Share?

Answer Field

The market cap of Metropolis Healthcare Ltd for NSE ₹ 1,03,22.98 & for BSE ₹ 1,03,07.10 as on Nov 21 2024 03:29 PM.

What is the P/E Ratio of Metropolis Healthcare Ltd Share?

Answer Field

As on Nov 21 2024 03:29 PM the price-to-earnings (PE) ratio for Metropolis Healthcare Ltd share is 78.30.

What is the PB ratio of Metropolis Healthcare Ltd Share?

Answer Field

As on Nov 21 2024 03:29 PM, the price-to-book (PB) ratio for Metropolis Healthcare Ltd share is 215.69.

How to Buy Metropolis Healthcare Ltd Share?

Answer Field

You can trade in Metropolis Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Metropolis Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Metropolis Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Metropolis Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader